The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”

Cancer Policy

HHS postpones third USPSTF meeting in a row

FDA approves leucovorin for cerebral folate deficiency

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members

House member introduces bill to increase funding for MCD testing of firefighters

USPSTF under threat of elimination, former members warn

Trump administration announces “major crackdown” on healthcare fraud

Clinical Roundup

Long-term analysis suggests follicular lymphoma can be cured, Fred Hutch study finds

Phase III persevERA study of giredestrant combination in ER-positive advanced breast cancer does not meet primary objective

Positive phase III results announced from the SUCCESSOR-2 study of oral mezigdomide in r/r MM

Researchers at VCU identify Achilles’ heel in lung cancer through common genetic mutation

Johns Hopkins scientists engineer nanoparticles able to seek and destroy diseased immune cells

Nutrition therapy extends survival by 34% in stage 4 pancreatic cancer patients, clinical trial shows

In The Clinic
Trials & Tribulations

Why infection and immunity matter for Florida’s cancer patients

FreeTrials & Tribulations
News Analysis
Health Equity
Latest Issue
Read the latest issue
Read the latest issue
DOWNLOAD THE PDF
UPCOMING EVENTS
Mar 2026
27
NCCN 2026 Annual Conference
May 2026
29
2026 ASCO Annual Meeting
Jun 2026
25
MASCC/ISOO 2026 Annual Meeting
View All Events

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account